GoodRx Holdings (GDRX) Gains from Investment Securities (2020 - 2022)

GoodRx Holdings (GDRX) reported Gains from Investment Securities of $1.2 million for Q4 2022, down 33.33% sequentially from $1.8 million in Q3 2022.

GoodRx Holdings (GDRX) Gains from Investment Securities (2020 - 2022) Analysis & Trends

GoodRx Holdings (GDRX) has 2 years of Gains from Investment Securities data on file, last reported at $1.2 million in Q4 2022.

  • For the quarter ending Q4 2022, Gains from Investment Securities changed N/A year-over-year to $1.2 million; the trailing twelve-month figure through Dec 2023 stood at $3.0 million (down 28.01% YoY), and the FY2022 full-year result was $18.1 million, changed N/A from the prior year.
  • Gains from Investment Securities eased to $1.2 million in Q4 2022, from $1.8 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $1.8 million in Q3 2022 to a low of $1.2 million in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 31.81 Bn 24.49 Bn 662.02 Mn
2 BrightSpring Health Services 14.76 Bn 13.86 Bn 482.22 Mn
3 Healthequity 8.36 Bn 8.10 Bn 256.31 Mn
4 Hinge Health 5.91 Bn 5.60 Bn 154.23 Mn
5 10x Genomics 5.89 Bn 5.35 Bn 106.18 Mn
6 MiniMed 4.45 Bn 4.16 Bn 480.00 Mn
7 Waystar Holding 4.41 Bn 4.35 Bn 216.84 Mn
8 Doximity 3.93 Bn 3.18 Bn 125.97 Mn
9 Privia Health 3.10 Bn 2.68 Bn -
10 GoodRx Holdings 1.04 Bn 802.91 Mn 173.85 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 1.20 Mn
Dec 31, 2022 1.20 Mn
Sep 30, 2022 1.80 Mn
Sep 30, 2022 1.80 Mn
Dec 31, 2020 1.17 Mn
Dec 31, 2020 1.17 Mn